Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
X4 Pharmaceuticals is a biotechnology business based in the US. X4 Pharmaceuticals stocks (XFOR.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.24 – a decrease of 2.03% over the previous week. X4 Pharmaceuticals employs 40 staff and has a market cap (total outstanding stock value) of $245.6 million.
Promoted
National Bank Direct Brokerage
Finder Award
Interactive Brokers
| Latest market close | $1.93 |
|---|---|
| 52-week range | $0.65 - $2.41 |
| 50-day moving average | $1.35 |
| 200-day moving average | $1.30 |
| Wall St. target price | $3.66 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.94 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $1.93 from 2023-05-30
| 1 week (2023-05-25) | -3.98% |
|---|---|
| 1 month (2023-05-01) | 22.93% |
| 3 months (2023-03-01) | 103.16% |
| 6 months (2022-12-01) | 34.03% |
| 1 year (2022-06-01) | 55.65% |
|---|---|
| 2 years (2021-06-01) | -79.68% |
| 3 years (2020-06-01) | 8.62 |
| 5 years (2018-06-01) | 17.51 |
| Gross profit TTM | $3 million |
|---|---|
| Return on assets TTM | -53.34% |
| Return on equity TTM | -189.21% |
| Profit margin | 0% |
| Book value | $0.42 |
| Market capitalisation | $245.6 million |
TTM: trailing 12 months
We're not expecting X4 Pharmaceuticals to pay a dividend over the next 12 months.
X4 Pharmaceuticals's shares were split on a 1:6 basis on 14 March 2019. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your X4 Pharmaceuticals shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for X4 Pharmaceuticals shares which in turn could have impacted X4 Pharmaceuticals's share price.
Over the last 12 months, X4 Pharmaceuticals's shares have ranged in value from as little as $0.65 up to $2.413. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while X4 Pharmaceuticals's is 0.2783. This would suggest that X4 Pharmaceuticals's shares are less volatile than average (for this exchange).
X4 Pharmaceuticals, Inc. , a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the treatment of CXCR4 disorders and primary immunodeficiencies. It has a license agreement with Abbisko Therapeutics Co. , Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
